PLAT and Cerebral ischemia: Although several treatments have been claimed to promote neuronal survival, reduce infarct volumes, and improve behavioral responses after experimental cerebral ischemia, the recombinant tissue plasminogen activator (rtPA) is the only FDA-approved drug for treatment of ischemic stroke clinically [28–30].